| 초록 |
Objectives: Peritoneal dialysis is a last resort for patients with end-stage renal disease who cannot undergo hemodialysis. Renal replacement peritoneal dialysis was introduced in Mongolia in 2014. An important part of peritoneal dialysis treatment is the surgery to place a catheter in the abdomen. This study was motivated by the lack of data on the impact of peritoneal dialysis on infection. Methods: In this study, 49 cases of a total of 102 doctors undergoing peritoneal dialysis treatment were included in Mongolia in 2014-2021. This study evaluated surveillance for peritoneal dialysis-related infections among peritoneal dialysis patients using a retrospective cohort study design. Participants' demographic information, comorbidities, and bacterial isolates were collected. All analyzes were performed using SPSS 25. Results: Currently, there are 38 /%/ CAPD, 7 /%/ APD, 3 /%/ APD + HD, and 1 /%/ CAPD + HD of peritoneal dialysis treatment in Mongolia. Out of 49 therapists, 26 /25%/ are being monitored in the city and 76 /75%/ in the local area. The average age of the participants is 31±11, 59.1% are women and 40.8% are men. 46.9% of all participants were infected with peritonitis and 28.5% were infected with catheter exit infection. Conclusions: Inadequate hand washing, loss of order of treatment, and pets affect the surveillance of infection due to peritoneal dialysis treatment. Therefore, it is very important to prevent and effectively treat infections due to peritoneal dialysis treatment. Peritoneal dialysis can be performed remotely and the patient can be monitored remotely. Peritoneal dialysis is the last option for patients with end-stage renal disease who are unable to undergo hemodialysis, which affects the lifespan of peritoneal dialysis, dialysis outcomes, and quality of life. In the future, nephrologists making peritoneal dialysis the first choice can preserve renal reserve, prevent complications of secondary hyperparathyroidism, improve patient quality of life, and prolong life. |